Literature DB >> 22764311

Medical risk factors for severe West Nile Virus disease, United States, 2008-2010.

Nicole P Lindsey1, J Erin Staples, Jennifer A Lehman, Marc Fischer.   

Abstract

We conducted enhanced surveillance to identify medical risk factors for severe illness (i.e., hospitalization or death) and neuroinvasive disease (i.e., encephalitis or meningitis) among all West Nile virus disease cases reported from selected states from 2008 to 2010. Of the 1,090 case-patients included in the analysis, 708 (65%) case-patients were hospitalized, 641 (59%) case-patients had neuroinvasive disease, and 55 (5%) case-patients died. Chronic renal disease (adjusted odds ratio [aOR] = 4.1; 95% confidence interval [CI] = 1.4-12.1), history of cancer (aOR = 3.7; 95% CI = 1.8-7.5), history of alcohol abuse (aOR = 3.0; 95% CI = 1.3-6.7), diabetes (aOR = 2.2; 95% CI = 1.4-3.4), and hypertension (aOR = 1.5; 95% CI = 1.1-2.1) were independently associated with severe illness on multivariable analysis. Although the same medical conditions were independently associated with encephalitis, only hypertension was associated with meningitis. The only condition independently associated with death was immune suppression. Prevention messages should be targeted to persons with these conditions.

Entities:  

Mesh:

Year:  2012        PMID: 22764311      PMCID: PMC3391046          DOI: 10.4269/ajtmh.2012.12-0113

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  20 in total

1.  Use and misuse of population attributable fractions.

Authors:  B Rockhill; B Newman; C Weinberg
Journal:  Am J Public Health       Date:  1998-01       Impact factor: 9.308

2.  Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1997-05-02

3.  West Nile virus activity - United States, 2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-07-02       Impact factor: 17.586

4.  Current practices and evaluation of screening solid organ donors for West Nile virus.

Authors:  R J Nett; M J Kuehnert; M G Ison; J P Orlowski; M Fischer; J E Staples
Journal:  Transpl Infect Dis       Date:  2012-05-20       Impact factor: 2.228

5.  The epidemiology and early clinical features of West Nile virus infection.

Authors:  Jacek M Mazurek; Kim Winpisinger; Barbara J Mattson; Rosemary Duffy; Ronald L Moolenaar
Journal:  Am J Emerg Med       Date:  2005-07       Impact factor: 2.469

6.  West Nile virus disease: a descriptive study of 228 patients hospitalized in a 4-county region of Colorado in 2003.

Authors:  Amy V Bode; James J Sejvar; W John Pape; Grant L Campbell; Anthony A Marfin
Journal:  Clin Infect Dis       Date:  2006-03-30       Impact factor: 9.079

7.  Risk factors for West Nile virus infection and meningoencephalitis, Romania, 1996.

Authors:  L L Han; F Popovici; J P Alexander; V Laurentia; L A Tengelsen; C Cernescu; H E Gary; N Ion-Nedelcu; G L Campbell; T F Tsai
Journal:  J Infect Dis       Date:  1999-01       Impact factor: 5.226

8.  Seroprevalence of West Nile virus infection in solid organ transplant recipients.

Authors:  A G Freifeld; J Meza; B Schweitzer; L Shafer; A C Kalil; A R Sambol
Journal:  Transpl Infect Dis       Date:  2009-10-22       Impact factor: 2.228

9.  Follow-up of 2003 human West Nile virus infections, Denver, Colorado.

Authors:  Jennifer L Patnaik; Heath Harmon; Richard L Vogt
Journal:  Emerg Infect Dis       Date:  2006-07       Impact factor: 6.883

10.  Risk factors for West Nile virus neuroinvasive disease, California, 2005.

Authors:  Cynthia M Jean; Somayeh Honarmand; Janice K Louie; Carol A Glaser
Journal:  Emerg Infect Dis       Date:  2007-12       Impact factor: 6.883

View more
  29 in total

1.  An outbreak of West Nile Virus infection in the region of Monastir, Tunisia, 2003.

Authors:  Samira Riabi; Imed Gaaloul; Maha Mastouri; Mohsen Hassine; Mahjoub Aouni
Journal:  Pathog Glob Health       Date:  2014-04       Impact factor: 2.894

2.  Emerging and reemerging neurologic infections.

Authors:  Felicia C Chow; Carol A Glaser
Journal:  Neurohospitalist       Date:  2014-10

Review 3.  Neuroinvasive arboviral disease in the United States: 2003 to 2012.

Authors:  James T Gaensbauer; Nicole P Lindsey; Kevin Messacar; J Erin Staples; Marc Fischer
Journal:  Pediatrics       Date:  2014-08-11       Impact factor: 7.124

4.  Comparison of Characteristics of Patients with West Nile Virus or St. Louis Encephalitis Virus Neuroinvasive Disease During Concurrent Outbreaks, Maricopa County, Arizona, 2015.

Authors:  Heather Venkat; Elisabeth Krow-Lucal; Melissa Kretschmer; Tammy Sylvester; Craig Levy; Laura Adams; Kathryn Fitzpatrick; Janeen Laven; Olga Kosoy; Rebecca Sunenshine; Kirk Smith; John Townsend; Jennifer Chevinsky; Morgan Hennessey; Jefferson Jones; Ken Komatsu; Marc Fischer; Susan Hills
Journal:  Vector Borne Zoonotic Dis       Date:  2020-04-06       Impact factor: 2.133

5.  Lack of evidence of increased West Nile virus disease severity in the United States in 2012.

Authors:  Nicole P Lindsey; J Erin Staples; Mark J Delorey; Marc Fischer
Journal:  Am J Trop Med Hyg       Date:  2013-11-11       Impact factor: 2.345

Review 6.  West Nile virus: review of the literature.

Authors:  Lyle R Petersen; Aaron C Brault; Roger S Nasci
Journal:  JAMA       Date:  2013-07-17       Impact factor: 56.272

Review 7.  Current developments in understanding of West Nile virus central nervous system disease.

Authors:  Kenneth L Tyler
Journal:  Curr Opin Neurol       Date:  2014-06       Impact factor: 5.710

8.  Vector Surveillance, Host Species Richness, and Demographic Factors as West Nile Disease Risk Indicators.

Authors:  John M Humphreys; Katherine I Young; Lee W Cohnstaedt; Kathryn A Hanley; Debra P C Peters
Journal:  Viruses       Date:  2021-05-18       Impact factor: 5.048

9.  Cost-Effectiveness and Impact of a Targeted Age- and Incidence-based West Nile Virus Vaccine Strategy.

Authors:  Emily J Curren; Manjunath B Shankar; Marc Fischer; Martin I Meltzer; J Erin Staples; Carolyn V Gould
Journal:  Clin Infect Dis       Date:  2021-11-02       Impact factor: 20.999

10.  Morbidity, mortality and long-term sequelae of West Nile virus disease in Québec.

Authors:  N Ouhoumanne; A-M Lowe; A Fortin; D Kairy; A Vibien; J K-Lensch; T-N Tannenbaum; F Milord
Journal:  Epidemiol Infect       Date:  2018-03-28       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.